Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from
dividing so they stop growing or die. Vaccines made from a patient's tumor tissue may make
the body build an immune response to kill tumor cells. Chemotherapy combined with vaccine
therapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining cyclophosphamide with tumor
cell vaccine in treating patients who have metastatic cancer or cancer at high risk of
recurrence.